tradingkey.logo
tradingkey.logo
Search

Evommune Inc

EVMN
Add to Watchlist
11.480USD
+0.120+1.06%
Close 07-27 16:00ETQuotes delayed by 15 min
413.49MMarket Cap
LossP/E TTM

EVMN Financials

See Evommune Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Evommune Inc Earnings Date

Latest Release
May 10, 2026
EPS / Forecast
-0.64/-0.73
Revenue / Forecast
0.00/0.00
Period
FY2025 Earnings
Revenue(YoY)
13.00M
85.71%
EPS(YoY)
-2.29
-0.82%
Analyst Rating
BUY
2026/07/27
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q2
Financial Indicators
EPS
---0.64
----
----
Revenue
--0.00
--0.00
----
Net Profit
---21.67M
---28.27M
----
Debt to assets ratio
--0.34%
--0.23%
--0.77%
Revenue
--0.00
--0.00
----
Operating profit
---23.95M
---29.72M
----
Net Profit
---21.67M
---28.27M
----
Current assets
--215.85M
--153.48M
--94.89M
Total current liabilities
--10.60M
--17.91M
--10.09M
Total assets
--322.45M
--224.95M
--96.21M
Total liabilities
--17.90M
--19.38M
--10.44M
Total equity
--304.56M
--205.57M
--85.77M
Net operating income
---27.50M
----
----
Net investment
---85.36M
----
----
Net financing
--117.11M
----
----

FAQs

What is the total revenue of Evommune Inc?

According to Evommune Inc's FY2025 earnings report, its total revenue reached 13.00M, with a year-on-year change of 7.00M.

What are the current assets of Evommune Inc?

According to Evommune Inc's FY2025 earnings report, its current assets were 153.48M, with a year-on-year change of 107.44.

What are the total assets of Evommune Inc?

According to Evommune Inc's FY2025 earnings report, its total assets of Evommune Inc were 224.95M, with a year-on-year change of 195.77.

What are the total liabilities of Evommune Inc?

According to Evommune Inc's FY2025 earnings report, its total liabilities of Evommune Inc were 19.38M, with a year-on-year change of -32.04.

What is the total equity of Evommune Inc?

According to Evommune Inc's FY2025 earnings report, its total equity of Evommune Inc was 205.57M, with a year-on-year change of 332.42.

What is the net operating income of Evommune Inc?

According to Evommune Inc's FY2025 earnings report, its net operating income of Evommune Inc was -81.07M, with a year-on-year change of -15.79.

What is the net investment of Evommune Inc?

According to Evommune Inc's FY2025 earnings report, its net investment of Evommune Inc was -115.31M, with a year-on-year change of -2787.73.

What is the net financing of Evommune Inc?

According to Evommune Inc's FY2025 earnings report, its net financing of Evommune Inc was 220.76M, with a year-on-year change of 346.72.

What is the Earnings Per Share (EPS) of Evommune Inc?

According to Evommune Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.29, with a year-on-year change of -0.82.

What is the net income of Evommune Inc?

According to Evommune Inc's FY2025 earnings report, its net income was -68.87M, with a year-on-year change of -0.82.

What is the net margin of Evommune Inc?

According to Evommune Inc's FY2025 earnings report, its net profit margin was -529.77, with a year-on-year change of 44.49.

What is the debt-to-asset ratio of Evommune Inc?

According to Evommune Inc's FY2025 earnings report, its debt-to-asset ratio was 0.23, with a year-on-year change of -98.21.

What is the Return on Assets (ROA) of Evommune Inc?

According to Evommune Inc's FY2025 earnings report, its Return on Assets (ROA) was -45.76, with a year-on-year change of 45.78.

What is the operating profit of Evommune Inc?

According to Evommune Inc's FY2025 earnings report, its operating profit was -81.07M, with a year-on-year change of -15.79.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.